It's wonderful you're keeping up with autism research! I wanted to share some specific updates regarding Dravet syndrome that you might find encouraging.

A recent gene-regulation therapy called zorevunersen is showing great promise in clinical trials, improving seizure frequency, language, motor skills, and behavior. This is especially exciting because current treatments don't address the underlying genetic cause of Dravet syndrome. Also, research indicates that behavioral and social difficulties can emerge as early as age 3 in children with Dravet syndrome, so early intervention is key. You can find more information at dravetfoundation.org/aes-2025-big-moments-and-emerging-insights-for-dravet-syndrome/ and news.northwestern.edu/stories/2026/03/first-gene-regulation-clinical-trials-for-epilepsy-show-promising-results?fj=1.